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ORIGINAL ARTICLE
Retinol Binding Protein 4 and Retinol in
Steatotic and Nonsteatotic Rat Livers in the
Setting of Partial Hepatectomy Under
Ischemia/Reperfusion
Maria Elias-Miro,1* Marta Massip-Salcedo,1,2* Jens Raila,3 Florian Schweigert,3 Mariana Mendes-Braz,4
Fernando Ramalho,4 Monica B. Jimenez-Castro,1 Aranı´ Casillas-Ramı´rez,1 Raquel Bermudo,5
Antoni Rimola,2,6 Juan Rodes,1,2 and Carmen Peralta1,2
1August Pi i Sunyer Institute for Biomedical Research, Barcelona, Spain; 2Network Center for Biomedical
Research in Hepatic and Digestive Diseases, Barcelona, Spain; 3Institute of Nutritional Science, University of
Potsdam, Nuthetal, Germany; 4Department of Pathology and Forensic Medicine, Faculty of Medicine,
University of Sa˜o Paulo, Sa˜o Paulo, Brazil; and 5Tumour Bank; and 6Liver Unit, Hospital Clinic, Barcelona, Spain
Steatotic livers show increased hepatic damage and impaired regeneration after partial hepatectomy (PH) under ischemia/
reperfusion (I/R), which is commonly applied in clinical practice to reduce bleeding. The known function of retinol-binding
protein 4 (RBP4) is to transport retinol in the circulation. We examined whether modulating RBP4 and/or retinol could pro-
tect steatotic and nonsteatotic livers in the setting of PH under I/R. Steatotic and nonsteatotic livers from Zucker rats were
subjected to PH (70%) with 60 minutes of ischemia. RBP4 and retinol levels were measured and altered pharmacologically,
and their effects on hepatic damage and regeneration were studied after reperfusion. Decreased RBP4 levels were
observed in both liver types, whereas retinol levels were reduced only in steatotic livers. RBP4 administration exacerbated
the negative consequences of liver surgery with respect to damage and liver regeneration in both liver types. RBP4 affected
the mobilization of retinol from steatotic livers, and this revealed actions of RBP4 independent of simple retinol transport.
The injurious effects of RBP4 were not due to changes in retinol levels. Treatment with retinol was effective only for steatotic
livers. Indeed, retinol increased hepatic injury and impaired liver regeneration in nonsteatotic livers. In steatotic livers, retinol
reduced damage and improved regeneration after surgery. These benefits of retinol were associated with a reduced accu-
mulation of hepatocellular fat. Thus, strategies based on modulating RBP4 could be ineffective and possibly even harmful in
both liver types in the setting of PH under I/R. In terms of clinical applications, a retinol pretreatment might open new ave-
nues for liver surgery that specifically benefit the steatotic liver. Liver Transpl 18:1198-1208, 2012. VC 2012 AASLD.
Received February 27, 2012; accepted June 3, 2012.
In clinical situations, partial hepatectomy (PH) under
ischemia/reperfusion (I/R) is usually performed to
control bleeding during parenchymal dissection.1
Hepatic steatosis, a major risk factor for liver surgery,
is associated with an increased complication index
and increased postoperative mortality after major liver
Abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase; BrdU, bromodeoxyuridine; HGF, hepatocyte growth
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protein 4; TGF-b, transforming growth factor b; TTR, transthyretin; I/R(RT), ischemia/reperfusion at different reperfusion times.
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resection.1 In comparison with nonsteatotic livers,
steatotic livers show impaired regenerative responses
and reduced tolerance to hepatic damage.2
Retinol-binding protein 4 (RBP4) is an adipokine
synthesized by the liver; its known function is to
transport retinol in the circulation.3 The mobilization
of liver vitamin A, which is stored predominantly as
retinyl esters, requires the hydrolysis of retinyl esters
to free retinol.4,5 The retinol-RBP4 complex is secreted
into the circulation, in which it binds transthyretin
(TTR). The association of RBP4 with TTR stabilizes the
complex in the circulation. Upon the delivery of retinol
to target cells, RBP4 loses its affinity for TTR and is
then eliminated through the kidneys.4,5 It should be
considered that RBP4 is not merely a transport pro-
tein for retinol. Indeed, RBP4 directly exerts injurious
effects in several pathologies, including diabetes and
cardiovascular diseases.3,6,7 However, the administra-
tion of RBP4 has been reported to be beneficial
against I/R damage in steatotic liver transplantation.8
In the present study, we examined whether the
modulation of RBP4 could protect steatotic and/or
nonsteatotic livers against damage and regenerative
liver failure after PH under I/R. Because of the central
importance of RBP4 in the homeostatic regulation of
retinol,9 we evaluated whether changes in RBP4 levels
induced by PH under I/R could affect the circulating
and tissue levels of retinol. Indeed, the accumulation
of retinol in the liver during inflammation and the low
plasma retinol levels observed in different pathologies
have been attributed to a decrease in hepatic RBP4
synthesis.10,11 We also investigated the role of retinol
in nonsteatotic and steatotic livers in the setting of PH
under I/R, which is commonly applied in clinical
practice to reduce blood loss. To the best of our
knowledge, only 1 experimental study of hepatic I/R
(notably focused on nonsteatotic livers without hepa-
tectomy) has reported that a derivative of retinol (all-
trans retinoic acid) protects against I/R damage.12
Some studies of PH without vascular occlusion that
have focused on nonsteatotic livers have reported
apparently controversial effects of retinol or its deriva-
tives on hepatic regeneration.13,14 A greater under-
standing of the role of retinol in the setting of PH
under I/R could contribute to the development of new
pharmacological strategies for hepatic resections.
MATERIALS AND METHODS
Experimental Animals
Male, homozygous, obese (Ob) Zucker rats (400-450
g) and male, heterozygous, lean (Ln) Zucker rats (350-
400 g; Iffa Credo, France) that were 14 to 16 weeks
old were used in these experiments. The Ob Zucker
rats showed severe macrovesicular and microvesicular
fatty infiltration in hepatocytes (60%-70% steatosis),
whereas the Ln Zucker rats showed no evidence of
steatosis. This study complied with European Union
regulations on animal experiments (directive 86/609/
EEC).
Surgical Procedure
The experiments in this study employed a rat model
of PH (70%) with 60 minutes of ischemia, as previ-
ously described.15 Briefly, after anesthesia with iso-
flurane and resection of the left hepatic lobe, a micro-
vascular clamp was placed for 60 minutes across the
portal triad supplying the median lobe. Congestion of
the bowel was prevented during the clamping period
through the preservation of the portal flow through
the right and caudate lobes. At the end of ischemia,
the right lobe and caudate lobes were resected, and
reperfusion of the median lobe was achieved by the
release of the clamp.
Experimental Design
Protocol 1
The effects of RBP4 and retinol on the parameters of
liver regeneration and damage 24 hours after reperfu-
sion were examined:
1. Sham group (Ln and Ob rats). The hepatic hilar
vessels of the animals were dissected.
2. PHþI/R group (Ln and Ob rats). The animals
underwent PH (70%) with 60 minutes of
ischemia.15
3. PHþI/RþRBP4 group (Ln and Ob rats). The ani-
mals were treated as the animals in group
2 were, but they were also treated with RBP4
(5 lg/kg intravenously) before the surgical
procedure.8
4. PHþI/Rþretinol group (Ln and Ob rats). The ani-
mals were treated as the animals in group 2
were, but they were also treated with retinol (10
mg/kg intraperitoneally) before the surgical
procedure.16
5. PHþI/RþRBP4þretinol group (Ob rats). The ani-
mals were treated as the animals in group 2
were, but they were also treated with RBP4 (5 l/
kg intravenously) and retinol (10 mg/kg intra-
peritoneally) before the surgical procedure.8,16
RBP4 and retinol levels, hepatic damage (transami-
nases and damage scores), liver regeneration parame-
ters [percentages of Ki-67–positive hepatocytes and
levels of hepatocyte growth factor (HGF) and trans-
forming growth factor b (TGF-b)], retinyl ester and
TTR levels, and RBP4/retinol ratios were determined
for the groups corresponding to protocol 1 24 hours
after reperfusion.
Protocol 2
This protocol involved the reperfusion time–dependent
effects of retinol on hepatic damage, proliferative ac-
tivity, and the degree of steatosis. To establish a rela-
tionship between the effects of retinol and proliferative
activity in steatotic and nonsteatotic livers, we sub-
jected animals to interventions similar to those used
for groups 2 and 4 (protocol 1), but the samples were
obtained 12, 24, and 48 hours after reperfusion.
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Bromodeoxyuridine (BrdU) was administered intra-
peritoneally at 50 mg/kg 1 hour before the animals
were sacrificed at the indicated times, and they were
processed to determine the incorporation of BrdU and
mitotic indices.17 Under these conditions, hepatic
damage (transaminases and damage scores) and the
degree of steatosis were also evaluated.
The interventions and measurements used in proto-
cols 1 and 2 are shown in Fig. 1. The doses and pre-
treatment times used for RBP4 and retinol were
selected on the basis of previous studies8,16 and pre-
liminary studies by our group. Control experiments
were performed with the corresponding vehicle for
each drug (saline and dimethyl sulfoxide for RBP4
and retinol, respectively).
Biochemical Determinations
Aspartate aminotransferase (AST), alanine amino-
transferase (ALT), HGF (a potent mitogen), total and
active TGF-b (considered the main inhibitor of hepatic
proliferation), RBP4, and triglycerides were measured
as described elsewhere.8,15,18
Analytical Determination of Retinol
and Retinyl Esters
Retinol and retinyl esters were measured with a
reversed-phase high-performance chromatography
system (Waters, Eschborn, Germany).19 Vitamin A
was extracted from the plasma and liver and was sep-
arated on a C18 column (Repro-Sil 70, Alltech Grom,
Rottenburg-Hailfingen, Germany). Retinol and retinyl
esters were quantified by the measurement of the
absorption at 325 nm with a photodiode array detec-
tor (model 996, Waters). The detection limits for reti-
nol and retinyl palmitate were 2.0 and 2.4 ng, respec-
tively; the coefficient of variation between runs was
4%, and the recovery rate was greater than 95%.
Real-Time Reverse-Transcription
Polymerase Chain Reaction
Quantitative real-time reverse-transcription polymer-
ase chain reaction analyses were performed with
Assays-on-Demand TaqMan probes (Rn01451317_g1
for RBP4 and Rn00667869_m1 for b-actin, Applied
Biosystems, Foster City, CA) according to the manu-
facturer’s protocol.8
Western Blotting
Western blotting for TTR was performed as described
elsewhere.20 Anti-TTR antibodies were acquired from
DakoCytomation (Hamburg, Germany). Immunoreac-
tive protein bands were visualized with chemilumines-
cence reagents and were quantified densitometrically
with Quantity One software.
Histology, Red Oil Staining, and
Immunohistochemistry
To appraise the severity of hepatic injury, we graded
hematoxylin and eosin–stained sections with a point-
counting method on an ordinal scale: (0) minimal or
no evidence of injury; (1) mild injury consisting of
cytoplasmic vacuolation and focal nuclear pyknosis;
(2) moderate to severe injury with extensive nuclear
pyknosis, cytoplasmic hypereosinophilia, and a loss
of intercellular borders; (3) severe necrosis with
Figure 1. Flow chart of the interventions and measurements corresponding to protocols 1 and 2: (1) effects of RBP4 and retinol on
the parameters of liver regeneration and damage 24 hours after reperfusion in the PHþI/R, PHþI/RþRBP4, PHþI/Rþretinol, and
PHþI/RþRBP4þretinol groups and (2) reperfusion time–dependent effects of retinol on hepatic damage, proliferative activity, and the
degree of steatosis throughout reperfusion (12-48 hours) in the PHþI/R(RT) and PHþI/R(RT)þretinol groups.
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disintegration of hepatic cords, hemorrhaging, and
neutrophil infiltration; and (4) very severe necrosis
with disintegration of hepatic cords, hemorrhaging,
and neutrophil infiltration.8,21 Liver steatosis was
evaluated via red oil staining on frozen specimens,
and the percentage of steatosis was calculated by
image analysis according to the standard procedure.18
For liver regeneration, liver samples were immuno-
stained with a rabbit monoclonal antibody against Ki-
67 (clone SP6, Abcam, Cambridge, MA), developed
with diaminobenzidine, and counterstained with he-
matoxylin.22 The percentages of proliferating hepato-
cytes were also estimated through the quantification
of hepatocytes that incorporated BrdU. BrdU-positive
cells were detected with a mouse anti-BrdU antibody
(GE Healthcare, United States).17 The mitotic index
was determined in hematoxylin and eosin–stained
liver sections.15 At least 30 high-power fields were
counted.
Statistics
Data are expressed as means and standard devia-
tions, and they were compared statistically via a 1-
way analysis of variance and then a post hoc Student-
Newman-Keuls test; a P value < 0.05 was considered
significant. The Spearman correlation coefficient was
used to investigate correlations between the effects of
retinol therapy and the degree of steatosis; P values <
0.05 were considered statistically significant.
RESULTS
Effect of RBP4 24 Hours After Reperfusion
RBP4 Levels in Steatotic and Nonsteatotic Livers
The RBP4 messenger RNA (mRNA) and protein levels
in nonsteatotic and steatotic livers from the PHþI/R
group were lower than the levels in livers from the
sham group (Fig. 2). The plasma RBP4 levels showed
a pattern similar to that described for hepatic RPB4
levels (data not shown).
Hepatic Damage and Regeneration
The administration of RBP4 exacerbated hepatic dam-
age in steatotic and nonsteatotic livers from the
PHþI/RþRBP4 group and increased damage scores
and transaminase levels in comparison with the
PHþI/R group (Fig. 3A). The number of Ki-67–positive
hepatocytes in both liver types was lower for the
PHþI/RþRBP4 group versus the PHþI/R group. This
decrease in proliferative cells was associated with low
HGF levels and high levels of active TGF-b (Fig. 3A);
the total hepatic TGF-b levels were similar for all
groups (data not shown). We confirmed that the
administration of RBP4 at the used dose raised RBP4
levels in both liver types with respect to the levels in
the sham group. The RBP4 (pmol/g of tissue) protein
levels in steatotic livers from the sham, PHþI/R, and
PHþI/RþRBP4 groups were 242.17 6 19.55, 82.41 6
3.91, and 239.18 6 20.62, respectively (P < 0.05 for
the PHþI/RþRBP4 group versus the PHþI/R group; P
¼ not significant for the PHþI/RþRBP4 group versus
the sham group).
Figure 2. RBP4 mRNA and protein levels and retinol levels in
both liver types 24 hours after reperfusion. Six Ln animals and
6 Ob animals from each group were included for each
measurement. The retinol levels in steatotic livers from the sham
group were higher than the levels in nonsteatotic livers. The
polymerase chain reaction fluorescent signals for RBP4 were
normalized to the signals obtained from an endogenous
reference (b-actin). The b-actin–normalized RBP4 mRNA levels
were calculated with respect to the levels of the sham control
group with the 2DDCt method. *P < 0.05 versus sham animals;
#P < 0.05.
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Effect of Retinol 24 Hours After Reperfusion
Retinol Levels in Steatotic and
Nonsteatotic Livers
In nonsteatotic livers, the retinol levels for the PHþI/R
group were similar to those for the sham group. The
retinol levels in steatotic livers from the sham group
were significantly higher than the levels in nonstea-
totic livers (Fig. 2), and this indicated that the pres-
ence of fatty infiltration in and of itself (without any
surgical intervention) induced changes in retinol me-
tabolism, as previously suggested.23 The retinol
Figure 3. (A) Effects of RBP4 and retinol (separately or in combination) on hepatic injury (plasma AST and ALT levels and liver
damage scores) and liver regeneration parameters (percentages of Ki-67–positive hepatocytes and plasma HGF and TGF-b levels) 24
hours after reperfusion. Six Ln animals and 6 Ob animals from each group were included for each measurement. *P < 0.05 versus
sham animals; þP < 0.05 versus PHþI/R animals. (B) Representative photographs of hematoxylin and eosin staining 24 hours after
reperfusion show extensive areas of coagulative necrosis in the PHþI/R, PHþI/RþRBP4, and PHþI/RþRBP4þretinol groups and small
areas of coagulative necrosis in the retinol group (scale bar ¼ 1000 lm). Representative photographs of immunohistochemical staining
of Ki-67–positive hepatocytes in steatotic livers 24 hours after reperfusion show that the number of Ki-67–positive hepatocytes was
lower in the PHþI/R, RBP4, and RBP4þretinol groups versus the retinol group (scale bar ¼ 1000 lm).
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levels in steatotic livers from the PHþI/R group
were reduced in comparison with the sham group.
Hepatic Damage and Regeneration
The effects of retinol were dependent on the type of
liver. The administration of retinol negatively affected
hepatic damage and liver regeneration in nonsteatotic
livers from the PHþI/Rþretinol group because the pa-
rameters of hepatic injury were higher than those for
the PHþI/R group. This was associated with reduced
percentages of Ki-67–positive hepatocytes, reduced
HGF levels, and high TGF-b levels in comparison with
the PHþI/R group (Fig. 3A). The administration of ret-
inol to Ob animals in the PHþI/Rþretinol group
reduced hepatic damage; this was indicated by the
reduction in transaminases and damage scores in
comparison with the PHþI/R group. Retinol adminis-
tration also increased the percentage of Ki-67–positive
hepatocytes in steatotic livers in comparison with the
PHþI/R group. This improvement was associated with
high HGF levels and low TGF-b levels (Fig. 3A).
Effects of RBP4 and Retinol in Combination 24
Hours After Reperfusion
Taken together, the results presented up to this point
show that neither the administration of RBP4 nor the
administration of retinol protects nonsteatotic livers
in the setting of PH under I/R. Because of our demon-
stration of the differential effects of RBP4 and retinol
on steatotic livers and data indicating that changes in
RBP4 induce changes in retinol levels,10,11 we eval-
uated whether the injurious effects of RBP4 with
respect to damage and regeneration in steatotic livers
could be explained by changes in retinol levels.
Hepatic Damage and Regeneration
The combined administration of RBP4 and retinol
resulted in injury and regeneration parameters for
steatotic livers from the PHþI/RþRBP4þretinol group
that were similar to those for steatotic livers from the
PHþI/RþRBP4 group (Figs. 3A). The histological anal-
ysis revealed severe, extensive, and confluent areas of
coagulative necrosis with neutrophil infiltration in
steatotic livers from the PHþI/R, PHþI/RþRBP4,
and PHþI/RþRBP4þretinol groups (Fig. 3B). The
liver damage scores for the PHþI/RþRBP4 and
PHþI/RþRBP4þretinol groups were significantly
higher than those recorded for the PHþI/R group.
Both the number and extent of necrotic areas in stea-
totic livers were reduced by retinol. In comparison
with the PHþI/R group, the PHþI/Rþretinol group
also exhibited an increased number of Ki-67–positive
hepatocytes in steatotic livers. The number of
Ki-67–positive hepatocytes in the PHþI/RþRBP4 and
PHþI/RþRBP4þretinol groups was lower than the
number in the PHþI/R group (Fig. 3A,B). Thus, the
administration of RBP4, separately or in combination
with retinol, negatively affected hepatic damage and
regeneration.
Retinyl Esters and Retinol in Liver and Plasma
Vitamin A is stored in the liver as retinyl esters, and
they must be hydrolyzed into retinol before vitamin A
can be mobilized into the circulation.4 In line with
this, retinyl ester and retinol levels in steatotic livers
were reduced for the PHþI/R group versus the sham
group (Fig. 4A). This decrease was associated with
high plasma retinol levels (Fig. 4B). As previously sug-
gested on the basis of studies in cultured cells,24
RBP4 could affect the storage and mobilization of reti-
nol in steatotic livers. In fact, we found that retinyl
ester levels (but not retinol levels) were increased in
steatotic livers (Fig. 4A) and circulating retinol levels
were reduced (Fig. 4B) for the PHþI/RþRBP4 group
versus the PHþI/R group or the sham group. As
expected, retinol administration increased both retinyl
ester and retinol levels in steatotic livers from the
PHþI/Rþretinol and PHþI/RþRBP4þretinol groups
versus the PHþI/R group and increased retinyl ester
levels (but not retinol levels) in plasma (Fig. 4A,B).
Our results confirmed that RBP4 administration led
to higher RBP4 levels in steatotic livers from the
PHþI/RþRBP4 and PHþI/RþRBP4þretinol groups
versus the PHþI/R group. For instance, the hepatic
RBP4 levels for the PHþI/RþRBP4þretinol and PHþI/R
groups were 239.6 6 21.65 and 82.41 6 3.91
respectively (P < 0.05). The hepatic RBP4 (pmol/g of
tissue) levels for the PHþI/Rþretinol group (83.45 6
4.56) were similar to the levels for the PHþI/R group
(82.41 6 3.91, P ¼ not significant).
Transport of Retinol in Plasma
Reduced plasma RBP4 levels were observed for the
PHþI/R group versus the sham group (Fig. 4C).
The plasma RBP4 levels for the PHþI/RþRBP4 and
PHþI/RþRBP4þretinol groups were lower than those
for the PHþI/R group. The plasma RBP4 levels for the
PHþI/Rþretinol group were similar to those for the
PHþI/R group. The plasma TTR levels were reduced for
the PHþI/R group versus the sham group, whereas the
TTR levels for the PHþI/RþRBP4, PHþI/Rþretinol, and
PHþI/RþRBP4þretinol groups were similar to those for
the sham group. It has been reported that retinol is nor-
mally found in plasma in a 1:1 molar ratio with RBP4.25
In the sham group, the RBP4/retinol ratio was approxi-
mately 2; in the PHþI/R and PHþI/RþRBP4 groups,
the RBP4/retinol ratio was greater than 1; and in the
PHþI/Rþretinol and PHþI/RþRBP4þretinol groups,
the RBP4/retinol ratio was less than 1 (Fig. 4C).
Reperfusion Time–Dependent Effect of Retinol
on Hepatic Damage, Proliferative Activity, and
Degree of Steatosis
Hepatic damage and proliferative activity in steatotic
and nonsteatotic livers were measured throughout
reperfusion (12, 24, and 48 hours; Fig. 5). In Ln ani-
mals, the parameters of hepatic injury were higher for
the partial hepatectomy under ischemia-reperfusion
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(PH+I/R) at different reperfusion times (RT) treated
with retinol (PHþI/R(RT)þretinol) group versus the
partial hepatectomy under ischemia-reperfusion
(PH+I/R) at different reperfusion times (RT)
(PHþI/R(RT)) group at each time point (Fig. 5A). In Ln
animals, the administration of retinol impaired the
mitotic index and hepatocellular BrdU incorporation
after reperfusion. For instance, the percentages for
BrdU-positive hepatocytes were 9.3% 6 1.09% and
19.5% 6 1.67% in the PHþI/R(RT)þretinol and PHþI/
R(RT) groups, respectively, 48 hours after reperfusion.
In Ob animals, the hepatic damage parameters were
lower for the PHþI/R(RT)þretinol group versus the
PHþI/R(RT) group at each time (Fig. 5B). Our results
revealed an improvement of the regenerative process
in steatotic livers from the PHþI/R(RT)þretinol group
versus the PHþI/R(RT) group. Thus, 48 hours after
reperfusion, the percentage of BrdU-positive hepato-
cytes was 17.3% 6 0.99% for the PHþI/R(RT)þretinol
group, whereas only 6.5% 6 0.76% of BrdU-labeled
hepatocytes were detected at that reperfusion time in
the PHþI/R(RT) group (Fig. 5B). Our results suggest a
relationship between the effects of retinol therapy and
the degree of steatosis in steatotic livers. Forty-eight
hours after reperfusion, increased hepatocellular fatty
infiltration and triglyceride levels were observed in the
PHþI/R(RT) group versus the sham group (Fig. 5C,D).
This is in line with a previous report of hepatic lipid
Figure 4. Effects of RBP4 and
retinol (separately or in
combination) on retinyl esters
and retinol in (A) steatotic livers
and (B) plasma and (C) RBP4 and
TTR levels and RBP4/retinol
ratios in plasma 24 hours after
reperfusion. Six Ob animals from
each group were included for
each measurement. *P < 0.05
versus sham animals; þP < 0.05
versus PHþI/R animals.
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Figure 5. Effects of retinol on hepatic injury (plasma AST and ALT levels) and liver regeneration (percentages of BrdU-positive
hepatocytes and mitotic indices) throughout reperfusion (12, 24, and 48 hours) in (A) Ln animals and (B) Ob animals. Eighteen Ln
animals and 18 Ob animals (6 Ln and 6 Ob animals for each reperfusion time) were included for each measurement. (C) Triglyceride
levels and steatosis percentages and (D) representative photographs of red oil staining 48 hours after reperfusion are shown. Steatotic
livers from the retinol group showed reduced fat globules (red) in hepatocytes in comparison with steatotic livers from the sham and
PHþI/R groups (scale bar ¼ 1000 lm). Six Ob animals from each group were included for each measurement. *P < 0.05 versus sham
animals; þP < 0.05 versus PHþI/R animals.
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accumulation during regeneration after PH.26 The
treatment with retinol decreased the accumulation of
fatty droplets and triglycerides in steatotic livers from
the PHþI/R(RT)þretinol group versus the PHþI/R(RT)
group. The steatosis percentages were 35.0% 6 1.78%
and 83.13% 6 3.40% for the PHþI/R(RT)þretinol and
PHþI/R(RT) groups, respectively, 48 hours after reper-
fusion. Figure 6 shows the relationship between the
effects of retinol therapy and the degree of steatosis 12,
24, and 48 hours after reperfusion. A significant corre-
lation between the degree of fat infiltration and the
plasma AST level (r ¼ 0.9677, P < 0.05) and an inverse
correlation between the degree of fat infiltration and
the mitotic index (r ¼ 0.9724, P < 0.05) were
observed. Treatment with retinol, therefore, attenuated
hepatic damage and improved hepatocellular prolifera-
tion during liver regeneration. This was associated with
a reduced accumulation of hepatocellular fat.
DISCUSSION
The decreased RBP4 levels observed in the circulation
after PH under I/R might reflect decreased hepatic
synthesis of RBP4 due to a loss of functional hepatic
tissue. Because the liver is the main site of RBP4 syn-
thesis,8,27 hepatocyte damage decreases circulating
RBP4 levels. Moreover, the synthesis of negative
acute-phase proteins such as RBP4 might be reduced
in the liver during inflammation or hepatic resection
as part of a compensatory response to the sudden
increase in the synthesis of positive acute-phase pro-
teins.11 The effects of RBP4 could depend on the sur-
gical conditions. Indeed, in contrast to steatotic liver
transplantation,8 RBP4 administration worsens liver
damage and regenerative failure in the setting of PH
under I/R.
Retinol is decreased in steatotic livers after PH
under I/R and is increased in plasma. This is consist-
ent with the increased secretion of retinol from stea-
totic livers into the circulation. However, other
hypotheses proposed for different liver diseases,28
including increased catabolism of retinol in the liver
and decreased liver uptake of retinyl esters formed in
peripheral tissues, should not be discounted. Retinol
is normally found in plasma in a 1:1 molar ratio with
RBP4 (the RBP4/retinol ratio is approximately 1.0).29
However, in our study and in agreement with the
reports of others,4 the RBP4/retinol ratio for the
sham group of Ob (steatotic) animals was approxi-
mately 2, and this indicated that the proportion of
RBP4 in plasma was higher than the proportion of ret-
inol. In this context, it should be considered that
RBP4 is present as a holoform (retinol-bound) and an
apoform (retinol-unbound) because RBP4 may trans-
port and deliver other lipophilic molecules in addition
to retinol.6,30 A question that arises is how the high
plasma retinol levels in the PHþI/R group are main-
tained in light of the low plasma RBP4 and TTR levels.
Like RBP4, TTR is a negative acute-phase protein,
and the hepatic syntheses of both are also decreased
during inflammation.11 However, because the plasma
RBP4/retinol ratio in the PHþI/R group was greater
than 1, there was enough RBP4 to bind retinol despite
the reduced RBP4 levels. It could be assumed that the
reduced plasma TTR levels in the PHþI/R group were
also high enough to maintain the retinol-RBP4 com-
plex in plasma, insofar as there is usually a 3- to 5-
fold molar excess of circulating TTR with respect to
circulating RBP4.11,27 The lack of a correlation
between RBP4 and TTR levels in plasma under our
surgical conditions could be explained, at least in
part, by the differential clearance of RBP4 and TTR by
the kidneys: TTR has a higher molecular weight and
is, therefore, retained to a greater extent than RBP4.27
Moreover, TTR has additional functions (eg, the trans-
porter for T4).4
RBP4 exerted injurious effects on steatotic livers
with respect to damage and regeneration independ-
ently of retinol. Moreover, the changes in retinol me-
tabolism induced by RBP4 could have occurred sim-
ply as a result of disease progression and thus do not
explain the injurious effects of RBP4. The mechanism
behind this is unclear. Retinyl esters seem to be
affected by RBP4 administration, and this also
Figure 6. Relationship between the degree of steatosis and (A)
the plasma AST level (r ¼ 0.9677, P < 0.05) and (B) the mitotic
index (r ¼ 0.9724, P < 0.05): (n) Ob PHþI/R(RT)þretinol
animals 12 hours after reperfusion, (l) Ob PHþI/R(RT)þretinol
animals 24 hours after reperfusion, and (~) Ob PHþI/
R(RT)þretinol animals 48 hours after reperfusion.
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suggests that RBP4 has actions independent of simple
retinol transport. However, the RBP4-induced
increase in retinyl esters does not explain the injuri-
ous effects of RBP4. Indeed, the loss of retinoid
(rather than an increase in retinoid levels) contributes
to the development of hepatic diseases.31
Serum RBP4 levels are elevated in insulin-resistant
mice and humans with obesity and type 2 diabetes.
The transgenic overexpression of human RBP4 or the
injection of recombinant RBP4 into normal mice
causes insulin resistance. Conversely, the genetic de-
letion of RBP4 enhances insulin sensitivity.6 Elucidat-
ing whether RBP4 also has metabolic effects was not
an aim of the present study. Nevertheless, because of
our results, this seems to not be the case for our ex-
perimental model. The Ob Zucker rats used in the
present study have a mutated leptin receptor and, as
a result, are hyperphagic, Ob, and hyperinsulinemic.
They are insulin-resistant, but they have normal
blood glucose levels. Ob Zucker rats do not develop
diabetes. Ln Zucker rats maintain an Ln phenotype
throughout life, and they show normal blood insulin
and glucose levels. RBP4 administration did not alter
the plasma insulin or glucose levels in the Ob Zucker
rats undergoing PH and I/R (data not shown). Under
our conditions, there was no relationship between
RBP4 levels and insulin resistance. Indeed, Ln and
Ob Zucker rats in the sham group showed similar
RBP4 levels in the liver and plasma, and only Ob
Zucker rats are insulin-resistant. In contrast, Yang
et al.6 have shown that genetically Ob mice and high-
fat diet–induced Ob mice with insulin resistance ex-
hibit increased plasma RBP4 in comparison with Ln
controls. The differences in plasma RBP4 levels
observed in the 2 studies can be explained at least
partially by the differences in RBP4 regulation
between rats and mice.32 All these data indicate that
under our conditions, RBP4 does not affect insulin
resistance.
Further studies, which are not part of the objectives
of the present study, are required to answer why the
pharmacological modulation of RBP4 exerted damag-
ing effects in the setting of PH under I/R. It is possible
that the compensatory changes in the protein synthe-
sis of positive and negative acute-phase proteins,
which were necessary to restore protein homeostasis
after hepatic resection, were disturbed in the remain-
ing liver when RBP4 was administered. From a clini-
cal perspective, strategies based on modulating RBP4
might not be appropriate for hepatic resection or
under surgical conditions (including small-for-size
liver transplantation). When we administered RBP4 to
compensate for the reduced RBP4 levels induced by
liver surgery, we observed more injurious effects with
respect to damage and liver regeneration.
In contrast, pretreatment with retinol alone may
create new possibilities for therapeutic interventions
in the resection of steatotic livers. As expected, retinol
administration alone increased vitamin A storage in
the liver. The increase in retinyl esters (but not retinol
or RBP4) in plasma after retinol administration sug-
gests that retinol is incorporated as retinyl esters in
hepatocytes and is secreted together with lipoproteins.
Thus, retinol administration could supply vitamin A
to target tissues. Data indicate that the RBP4 mole-
cule contains 1 binding site for a single molecule of
retinol,25 so the fact that the RBP4/retinol ratio after
retinol administration was less than 1 might suggest
that a fraction of retinol is bound to carriers other
than RBP4, just as with other pathologies.33
The results presented here indicate that retinol
reduces damage and improves liver regeneration in an
experimental model combining PH and I/R. Unpub-
lished results from our group indicate that retinol
therapy for steatotic livers affects both I/R injury and
PH. Thus, retinol reduces hepatic damage in Ob rats
subjected to partial hepatic ischemia (60 minutes)
without hepatectomy. Retinol administration also
reduces hepatic damage and improves liver regenera-
tion in Ob rats subjected to 70% resection only (data
not shown).
Further studies will be required to explain how reti-
nol reduces lipid accumulation in the regenerating
liver after surgery. The effects of retinol on the mobili-
zation of fatty acids from peripheral stores and he-
patic lipogenesis, fatty acid oxidation, and triglyceride
secretory mechanisms in the liver should be explored
as possible answers to this question. Our results
show that the benefits of retinol with respect to dam-
age and liver regeneration in steatotic livers are asso-
ciated with reduced hepatic lipid accumulation. It has
been reported that it is crucial to reduce steatosis to
prevent the vulnerability of steatotic livers to I/R
injury and regenerative failure.34
In conclusion, PH under I/R affects hepatic vitamin
A metabolism by reducing hepatic RBP4 expression
and increasing the mobilization of retinol into the cir-
culation. The results presented here suggest that
under surgical conditions requiring liver regeneration,
modulating RBP4 levels worsens the outcome and is,
therefore, not advised. This study also points to new
possibilities for therapeutic interventions based on
retinol pretreatment to protect steatotic livers against
damage and regenerative failure after liver surgery.
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